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Background:The absence of incorporation between endoprosthesis (EP) and the arterial wall may lead to device migration
and endoleaks around the stent graft. Alternatives have been tested aiming to improve this incorporation. Fibrin glue is
used in many operating procedures promoting adhesion and tissue regeneration; however, its use to improve EP
incorporation by arteries is unknown.
Objective: The objective of this study was to analyze dislodgement forces needed to extract the EPs implanted in pig aorta,
compare different oversizing and fibrin glue injections, and to analyze histologic changes among groups.
Methods: Straight EPs were implanted in the thoracic aorta of pigs using 10% oversizing plus fibrin glue in the interface
between the EP and the artery (group 1), using 20% oversizing (group 2), and 10% oversizing (group 3). Fourteen days
after the implant, the animals were killed to enable biomechanical analysis of the EP and to verify histologic changes of
the aortic wall and its interface with the EP.
Results: Group 1 showed a dislodgement force of 21.9  5.3 Newton (N) being higher than the other groups and
statistically significant when compared to group 3 (15.6  3.6N), P  .003%. Group 2 had a higher dislodgement force
and statistically more significant than group 3 (19.5  7.8N). Histologic analysis showed tissue reaction with
inflammatory cells and fibroblasts higher in group 1 and group 2 compared to group 3.
Conclusion: This study reports a large animal survival model of thoracic aortic stent graft placement by testing the impact
of fibrin glue on EP incorporation. Compared to oversizing alone, fibrin glue placed between the stent graft and the
arterial wall increases EP incorporation. Additional studies are needed to determine the potential utility of fibrin glue in
the setting of human arterial endografts. ( J Vasc Surg 2011;53:1368-74.)
Clinical Relevance: The incorporation of stent grafts never occurs and migration is a common problem. The EP resource
fixation is oversizing, which has been empirically determined to be between 10% and 30%. In this article, biomechanical
studies provided an evaluation about the oversizing and the forces for displacement of the EP. Moreover, successful
initiatives have been done to improve the incorporation of the stent grafts. Our study used fibrin glue to improve the
incorporation and fixation of stent grafts. Fibrin glue applied to the interface of the EP/aorta promoted better fixation
of EPs, induced a more intense inflammatory reaction, and could be a very promising alternative in the development of
new materials.
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3Since the introduction of the aortic stent by Parodi et
al1 in 1990, there have been great developments in the
treatment of aortic aneurysms. There has been consistent
improvement in both the stent graft materials and surgical
technique. Endovascular aneurysm repair has become less
invasive and is a safe alternative, particularly for high-risk
patients.2
Despite advancements in material science and surgi-
cal techniques, not all patients have optimal outcomes
after surgery. This may be associated with structural graft
problems, the morphology of the aortic aneurysm, pro-
gression of the disease after surgery, or the hemodynamic
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1368orces and healing at the surgical site, and may lead to
igration and leakage.3,4 Complex mathematical calcu-
ations have revealed that the hemodynamic drag force of
ndoprostheses (EPs) implanted in the aorta is about
wo Newtons, suggesting that the stent graft must have
xation forces greater than this threshold to prevent
igration.5-7 Although endovascular aneurysm repair
as minimized the surgical impact, the aortic neck may
till undergo expansion over time.3 This enlargement is
ue to the remodeling process and progression of the
isease and seems to be more frequent in endovascular
epair. The high incidence of enlargement is typically
ttributed to the fact that EPs are self-expandable and
ontinuously exert a radial force on the aortic neck,
hich in turn dilates this structure. To reduce the migra-
ion, the addition of bare suprarenal stent, barbs, and
ooks have improved the devices.8,9 Another resource of
P fixation is oversizing, which has been empirically
etermined to be between 10% and 30%. Clinical studies
ave shown that 10% is insufficient, 20% is ideal, and
0% is excessive.8 Oversizing of 30% may increase neck
ilatation and folding of the EP, which can lead to
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Volume 53, Number 5 Almeida et al 1369endoleaks, enlargement of the aneurysm, and subse-
quent complications associated with migration.
The interface between the EP and the aorta is a critical
aspect associated with migration. The degree of incorpora-
tion varies depending on the material used to cover the
stent graft. Polyurethane has a higher degree of incorpora-
tion in a vascular wall, but this material also quickly degen-
erates within the human body. Polyester (Dacron) is a
material widely accepted for use in vascular surgery, it
induces the ingrowth of vascular cells from the aorta, and it
is a material that presents resistance in the long-term.
Polytetrafluoroethylene (PTFE) is used in several different
types of stents and is widely used in vascular surgery as an
arterial graft. However, PTFE has a hydrophobic surface,
and, therefore, this material has very little tissue interac-
tion.10-12 Successful initiatives have been done to im-
prove the incorporation of the stent grafts using growth
factors, collagen, and nitrite with chondroitin sul-
fate.13,14 To improve tissue adhesion strength and re-
duce excessive bleeding, fibrin sealants have been used in
bypass surgery, the repair of septal atrial defects, type A
aortic dissections, prosthetic patches, and in several
other cardiovascular procedures.15,16
Despite the frequent use of fibrin glue in cardiovascular
surgeries, no empiric studies have been conducted to eval-
uate the effect of fibrin glue on the incorporation and
fixation of stent grafts. Therefore, the purposes of this study
were to (1) establish a large animal model of aortic EP
delivery, survival, and explantation, and (2) to determine if
different prosthesis oversizing and use of fibrin glue im-
proves fixation of EPs.
METHODS
The experiment was previously approved by the Ethical
Committee on Animal Research and Experiments of Botu-
catu Medical School  Universidade Estadual Paulista. A
pilot study with 3 pigs was performed and six EPs were
implanted in their thoracic aorta (two per pig). The sample
size of the present study was calculated based on the pilot
work. Nine Landrace pigs weighing 41 to 53 kg (mean
weight 50 kg), and aged 4 to 5 months (mean age 4.5
months) were previously obtained. The mean thoracic aor-
tic diameter was 20 mm (ranging from 17-22 mm) and
mean length was 180 mm (ranging from 168-190 mm).
Two pigs called P1 and P4 died 6 hours after surgery, and
biomechanical tests were done but were not included in
Table I. Presentation of animals and endoprosthesis distri
P1 P2 P3 P4
EP1 10% 20% 10% 20%
EP2 20% 10% 20% 10%  G
EP3 10%  G 10%  G 10%  G 10%
EP4 10%
EP, Endoprosthesis position in thoracic aorta; G, glue; P, pigs.
Exclusion criteria  P1 and P4 represent the animals that died 6 hours aftestatistical analysis (see exclusion criteria). Seven pigs were Bsed and three EPs were implanted in each, with a total of
1 EPs (ranging from 18-26mm) and were included in this
tudy (Table I).
The criteria for exclusion were death, thrombosis of the
orta, or if there were any technical problems with the
mplant procedure. The EP used in each animal was over-
ized by either 10% or 20%, depending on the group. Three
roups were defined for the final analysis: EP with 10%
versizing  glue, EP with 20% oversizing without glue,
nd EP with 10% oversizing without glue (group 1, group
, and group 3, respectively). Each pig received three stents
n their thoracic aorta: one proximal, one in themiddle, and
ne in the distal site on a random allocation (E1, E2, and
3, respectively; Fig 1).
The EPs used were manufactured in diameter from 16
mup to 30mm, in increments of 1mm, but all had a fixed
ength of 40 mm; Z-nitinol stents were completely covered
y Dacron. None of the EPs had barbs or hooks (Braile
Fig 1. Endoprostheses implantation in positions E1, E2, and E3.
n
P5 P6 P7 P8 P9
20% 20% 10%  G 10%  G 10%  G
0% 10%  G 20% 20% 10%
%  G 10% 10% 10% 20%
rocedure.butio
1
10iomédica, São José do Rio Preto, São Paulo, Brazil).
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May 20111370 Almeida et alAfter an adjustment period of 7 days, a laparotomy was
performed and vascular access through the abdominal aorta
of pigs was obtained. The delivery system consisted of a
catheter with the stent graft inside, which was released
through the traditional pull-back system. The procedures
in pigs were performed while they were under general
anesthesia with isoflurane, after premedication with ace-
topromazine (Acepran; UNIVET, São Paulo, Brazil),
xylazine (Rompun; Bayer Schering Pharma, Wuppertal,
Germany), and ketamine (Ketalar; Pfizer, Guarulhos,
São Paulo, Brazil).
Angiography and evaluation of the EP implantation
was obtained using a Philips BV-300 (Philips, Miami, Fla).
The size of each portion of the thoracic aorta was deter-
mined from the angiograms using built-in software, which
was calibrated in a standardized manner using a pig-tail
catheter with 11marker bands spaced 1 cm apart (Performa
Merit Medical, Salt Lake City, Utah). Based on these
measurements, the oversizing of each stent graft was cho-
sen (Fig 2).
To implant the EP with adhesive tissue, a 12F (Arrow,
Hampton, Va) hemostatic valve was introduced through
aortotomy with the insertion of two catheters of the 5F 90
cm (Merit Medical), which were positioned in the thoracic
aorta. This valve was then removed and the applicator
system of the EP was inserted and then released. The
catheters were tractioned and repositioned at the upper end
of the prosthesis under fluoroscopy. Contrast injections
(1-3mL) were used to assess the positioning of the catheter
at the EP-aorta interface. After this procedure, fibrin glue
(Tissucol; Baxter, Deerfield, Ill) was injected. TheDuplojet
intracatheter system, which consisted of two syringes with a
Y connection, was used. One syringe contained fibrinogen
and aprotinin and the other contained Thrombin 4U and
CaCl2; 2.5 mL of fibrin glue was injected through each
catheter. In the postoperative period, no antiplatelets or
Fig 2. Aorta diameter measurement obtained by placing the soft-
ware marks over the border of artery walls delimited by angiogra-
phy contrast.anticoagulants were given. tAfter 14 days, the animals were killed by bleeding while
nder anesthesia. The thoracic aorta was perfused with
eparinized saline and removed en bloc. The aorta was
ivided into three segments corresponding to the positions
f E1, E2, and E3, and each segment consisted of the entire
evice plus 10 to 20 mm of aorta on either end.
For histologic analysis, a foam cylinder was placed
nside the artery with the EP and 2-mm sections were
emoved. The cylinder provided support during the re-
oval of the sample and prevented fragmentation and
amage of the vessel. The samples were fixed in 10%
amponated formaldehyde solution, processed in the tissue
rocessor (102 Leica, Wetzlar, Germany), and prepared on
araffin blocks using the Leica EG 1160. A total of 5-m
ections were made using a microtome (Leica RM 2155)
nd stained with hematoxylin and eosin. Analyses were
erformed by a veterinary pathologist who was blinded to
he group assignment.
Next, biomechanical tests were performed using a
niversal Testing Machine (Model EMIC, São José dos
inhais, Paraná, Brazil). Each aortic segment was con-
ected to a rough metallic cylinder on the machine
ystem and a parachute was made in the distal portion of
he EP, which was tied to the base of the equipment.
ension was applied at a constant rate of 30 mm/minute
ntil the EP was detached from the aorta (Fig 3). A
oad-deformation plot was automatically generated by
Fig 3. Diagram  Universal Machine for Mechanical Testing.he computer software. Two parameters were extracted
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Volume 53, Number 5 Almeida et al 1371from the load deformation data: maximum force – load
maximum value for displacement of the EP (Newtons
[N]) and maximum deformation – maximum elongation
of aorta before displacement from the EP (millimeters
[mm]).
A repeated measures analysis of variance was used to
assess the biomechanical data between groups and vessel
positions, followed by Tukey’s posthoc tests when ap-
propriate. A P value of .05 or less was considered signif-
icant. A qualitative analysis was made for histologic
results.
RESULTS
Two pigs called P1 and P4 died 6 hours after surgery.
In total, 7 pigs were used in the final analysis and three EPs
were implanted in each animal, giving a total of 21 EPs
(ranging from 18-26 mm; Table I). Transient paraplegia of
the pelvic limbs of all animals with complete recovery in
Fig 4. Aorta – 10% group – Space between the vessel wall and the
prosthesis filled with thrombotic mass constituted by thick layers of
fibrin, red blood cells, and leukocytes (hematoxylin and eosin,
20).
Table II. Results from tensile testing on pig 1 and pig 4
obtained 6 hours after endoprostheses implant
Animals Maximum force Maximum deformation
Pig 1a 2.4N 14.0 mm
E1 (10%)
E2 (20%) 3.8N 7.6 mm
E3 (10%  G) 7.2N 4.6 mm
E4 (10%) 2.6N 3.8 mm
Pig 4a 4.0N 8.0 mm
E1 (20%)
E2 (10%  G) 7.6N 12.0 mm
E3 (10%) 2.5N 4.6 mm
G, Glue; N, Newton.
aPig 1 and Pig 4 died 6 hours after surgery and, therefore, they were not
included in the statistical analysis.3-hour to 8-hour periods was observed in the postoperative geriod. Biomechanical tests were performed to assess the
orce needed to displace the EPs of the 2 animals that died
Table II), but the results from these animals were not
ncluded in the final statistical analysis. Fourteen days after
he implant, the thoracic aortas were removed and biome-
hanical and histologic analyses were performed. When the
ortas were removed, the presence of a detachable thin
rilliant layer covering the internal surface of the EP was
bserved, and the stent grafts were firmly fixed to the
rteries.
Histologic analysis showed thrombotic masses consist-
ng of thick layers of fibrin and leukocytes between the
essel wall and the prosthesis. There was no sign of endo-
helization of the luminal side of the prosthesis. In the 10%
roup, the organization level of the thrombus was less
ntense and restricted to small base areas adjacent to the
ntima (Fig 4). In the 20% group (Fig 5) and in the 10%
ig 5. Aorta – 20% group – Dacron covered by the organization
rocess next to the vessel intima (hematoxylin and eosin 20).
ig 6. Aorta – 10% group with glue – Dacron was covered by
broblasts and macrophages and incorporated to the organization
rocess next to the vascular wall depression area that goes deep to
he media layer (hematoxylin and eosin, 10).roup with glue (Fig 6), Dacron was covered with fibro-
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There was evidence of neorevascularization at the base of
the thrombus, and these neoformed vessels were lined by
hypertrophic endothelial cells.
No differences in maximum force and maximum
deformation were found between graft location in posi-
tions E1, E2, and E3 (P  .97 and P .85, respectively).
Differences were found between groups for maximum
force. Maximum force for group 1 and group 2 was
higher than maximum force for group 3 (P  .05). In
group 1 (10%  glue), maximum force was statistically
equal to group 2 (20%). There was no difference in the
maximum deformation variable among the groups (P 
.05; Table III).
DISCUSSION
Despite technological development of stent grafts, mi-
gration still remains a clinical problem. In a survey of several
articles, migration rates ranged from 2% to 45% of
cases.3,8,9 The incidence of migration depends on many
variables, including the criteria used to define migration,
the time to follow-up, and the specific measurement tech-
nique used to assess the presence of migration. The Society
for Vascular Surgery has recommended that migration be
defined as 10 mm dislodgement, although this value is not
yet a consensus among all physicians.17
Experimental evaluations have led to improvement in
prosthetic incorporation and biomechanical interactions.
Lambert et al4 implanted EPs in cadaveric aortas and eval-
uated their biomechanics. Based upon those findings, it was
recommended that a greater overlap of the EP on the artery
improves fixation. The authors also observed that a bigger
oversizing would result in an increase of radial force.Malina
et al18 observed that hooks and barbs further increased
anchoring force. Despite these investigations that led to
important clinical advancements, the interaction between
the living organism and the EP was not evaluated. In our
study, implantation of the prostheses in pigs better simu-
lated conditions observed in clinical practice, including
blood flow during implantation, and interactions with the
thermal conditions, coagulation factors, and inflammatory
processes in the organism. The subsequent evaluation of
prosthetic incorporation in a living organism expanded
upon the current understanding of stent grafts in vivo. In
Table III. Mean and SD related to the variables:
maximum force and maximum deformation, according to
the group
Group number Maximum force Maximum deformation
1 (10%  G) 21.9  5.3N 16.0  5.8 mm
2 (20%) 19.5  7.8N 15.4  6.2 mm
3 (10%) 15.6  3.6N 15.1  4.7 mm
P value .003* .95
*Statistically significant value  P  .05. Number per group  7.
G, Glue; N, Newton.addition, the displacement tests conducted on the Univer- bal Tensile Machine provided more precise evaluations of
he biomechanical properties after implantation.
Significant increases in the anchoring strength of the
P observed in all groups at 2 weeks of postimplantation
howed that the inflammatory process, even at an early
hase, is an important element in EP fixation.
In our study, we used oversizing of 10% to 20% to
imulate current clinical techniques of endovascular graft
mplantation. Differences between group 2 and group 3
ould be explained by the greater radial force of themetallic
tent graft in group 2, which penetrated deeper into the
unica media of the vascular wall and increased anchorage.
owever, because of equipment sensibility and the parallax
ffect, the oversizing measurement can result in less accu-
ate results, particularly when a small size aorta is used. To
void this, we used Landrace pigs weighing 50 kg (mean
eight) and the stent graft was placed in the thoracic aorta,
s close as possible to the subclavian artery.
Some authors19 have reported that larger oversizing
ncreases the inflammatory response in the vessel wall. In
mall arteries, such as the coronary arteries, a larger over-
izing intensifies the inflammatory process, intimal hyper-
lasia, and early arterial thrombosis.20,21 In larger arteries
uch as the aorta, a severe inflammatory process would
ncrease prosthesis fixation and reduce the chance of migra-
ions. In our study, histologic findings confirmed that the
0% group (group 2) had a greater fibroblastic reaction
nd inflammatory response compared to the 10% group
group 3).
The aortic wall in aneurysmal diseases shows struc-
ural alterations caused by transmural inflammatory pro-
esses, particularly destruction of elastic and collagen
bers caused by the proteases. These alterations make
he arterial wall more fragile22-24 and thus the additional
orce from oversizing could promote a dilation of the
ortic neck and consequent migration of the EP.3,25 The
deal EP would have a greater capacity to incorporate
nto the artery without requiring excessive oversizing.
herefore, efforts have been made to promote adhesion
nd migration of fibroblasts and smooth muscle cells in a
urface of endografts.
Lerouge et al13 impregnated the polyester and PTFE
abric of the prostheses with nitrogen-rich polymerized
lasma, and in another group with chondroitin sulfate,
hich is described as a mediator of vascular inflammatory
esponse. Using fibroblast and smooth muscle cell cul-
ures, the authors observed a significant increase in the
ngrowth of these cells into the impregnated prostheses
hen compared to the control group of standard pros-
heses. van der Bas et al14 implanted EPs impregnated
ith basic fibroblast growth factor and collagen in swine
ortas and compared the histologic results to non-
mpregnated prostheses. At 4 to 8 weeks after implanta-
ion, histologic analyses with optical and transmission
lectron microscopy showed a greater ingrowth reaction
n the impregnated group, characterized by foreign body
ype giant cells, formation of neointima, and myofibro-
lasts. The authors concluded that this method could be
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a consequent improvement of anchoring strength. In our
study, we found that the group with 10% oversizing with
fibrin glue had greater displacement forces compared to
the other groups. Compared to the 10% group without
glue, this difference was statistically significant (P 
.003), suggesting that endoprosthetic fixation can be
increased without excessive oversizing.
Cardon et al26 reported moderate intimal hyperplasia
and intense thickening around the prosthesis in pigs 14
days after implantation of open aortobifemoral grafting
impregnated with fibrin glue. The fibrin matrix acts as a
pathway that facilitates the migration of inflammatory cells.
These granulocytes, in turn, release cytokines with angio-
genic potential and stimulate migration of fibroblasts and
smooth muscle cells related to the incorporation process.
The use of substances that expedite tissue synthesis and
improve the efficiency of the graft is an attractive idea.27 In
our study, Tissucol fibrin glue, which is a biological con-
centrate made of plasma-derived components, was used. Its
action is similar to the last phase of the physiological
coagulation and the formation of stable fibrin. The clot
created by the glue is a component for tissue repair and it
differs from the other types of glues, such as cyanoacrylate,
which results in hard and inelastic fibrosis via foreign body
type reaction.28 Despite the benefits of commercial fibrin
glue, this product is obtained from a great group of donors,
increasing the potential risk of infectious diseases or “pri-
ons.”29 Glue obtained from a single donor reduces these
risks, and recently autologous tissue fibrin glue has been
produced bymachines in a short time.30 Future advances in
fibrin technology may offer optimal treatment options for
patients requiring endoprosthetic treatments.
In conclusion, animals who received grafts with 10%
oversizing fibrin glue had a more intense inflammatory
reaction and fibrosis with greater fixation than the group
with 10% oversizing alone. Fibrin glue applied to the
interface of the EP and aorta may improve EP fixation.
Impregnated EPs would potentially promote better fix-
ation and could be a very promising alternative in the
development of new materials. However, in this study,
tests were performed in thoracic aortas and data extrap-
olation to abdominal aorta should be done carefully.
Further evaluations and clinical studies are required to
confirm these results.
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